Metabolism - Clinical and Experimental
Volume 55, Issue 3 , Pages 324-330 , March 2006

Correlation between change in body weight rather than current body weight and change in serum adiponectin levels in a Japanese population—the Funagata study

  • Nobuko Arawaka

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata 990-9585, Japan
    • ,
  • Makoto Daimon

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata 990-9585, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 23 628 5316; fax: +81 23 628 318.
    • ,
  • Toshihide Oizumi

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata 990-9585, Japan
    • ,
  • Yumi Jimbu

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata 990-9585, Japan
    • ,
  • Wataru Kameda

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata 990-9585, Japan
    • ,
  • Hiroshi Yamaguchi

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata 990-9585, Japan
    • ,
  • Hiroshi Ohnuma

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata 990-9585, Japan
    • ,
  • Makoto Tominaga

      Affiliations

    • Department of Laboratory Medicine, Yamagata University School of Medicine, Yamagata 990-9585, Japan
    • ,
  • Takeo Kato

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata 990-9585, Japan

Received 11 March 2005 ,Accepted 7 September 2005.

References 

  1. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106:473–481
  2. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced extensively in adipocytes. J Biol Chem. 1995;270:26746–26749
  3. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol. 2003;14:561–566
  4. Daimon M, Oizumi T, Saitoh T, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population—the Funagata study. Diabetes Care. 2003;26:2015–2020
  5. Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab. 2002;87:2764–2769
  6. Stefan N, Bunt JC, Salbe AD, Funahashi T, Matsuzawa Y, Tataranni PA. Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. J Clin Endocrinol Metab. 2002;87:4652–4656
  7. Stefan N, Vozarova B, Funahashi T, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes. 2002;50:1884–1888
  8. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930–1935
  9. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20:1595–1599
  10. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79–83
  11. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. 2002;13:84–89
  12. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941–946
  13. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001;7:947–953
  14. Maeda N, Schimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 2002;8:731–737
  15. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2002;290:1084–1089
  16. Yu JG, Javorschi S, Hevener AL, et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes. 2002;51:2968–2974
  17. Motoshima H, Wu X, Sinha MK, et al. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab. 2002;87:5662–5667
  18. Guldstrand M, Ahrén B, Adamson U. Improved β-cell function after standardized weight reduction in severely obese subjects. Am J Physiol. 2003;284:E557–E565
  19. Faraj M, Havel PJ, Phélis S, Blank D, Sniderman AD, Cianflone K. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2003;88:1594–1602
  20. Hulver MW, Zheng D, Tanner CJ, et al. Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol. 2002;283:E861–E865
  21. Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001;86:3815–3819
  22. Raitakari M, Ilvonen T, Ahotupa M, et al. Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol. 2004;24:124–128
  23. Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle change on vascular inflammatory markers in obese women. A randomized trial. JAMA. 2003;289:1799–1804
  24. Arvidsson E, Viguerie N, Anderson I, Verdich C, Langin D, Arner P. Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. Diabetes. 2004;53:1966–1971
  25. Abbasi F, Lamendola C, McLaughlin T, Hayden J, Reaven GM, Reaven PD. Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women. Metabolism. 2004;53:250–283
  26. Oizumi T, Daimon M, Saitoh T, et al. Genotype Arg/Arg, but not Trp/Arg, of the Trp64Arg polymorphism of the β3-adrenergic receptor is associated with type 2 diabetes and obesity in a large Japanese sample. Diabetes Care. 2001;24:1579–1583
  27. Jebb SA, Cole TJ, Doman D, Murgatroyd PR, Prentice AM. Evaluation of the novel Tanita body-fat analyser to measure body composition by comparison with a four-compartment model. Br J Nutr. 2000;83:115–122
  28. Ogawa K, Ueda K, Sasaki H, et al. History of obesity as a risk factor for both carotid atherosclerosis and microangiopathy. Diabetes Res Clin Pract. 2004;66S:S165–S168
  29. Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 2002;360:57–58
  30. Fumeron F, Aubert R, Siddiq A, et al. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period—the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes. 2004;53:1150–1157
  31. Hotta K, Funahashi T, Bodkin NL, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes. 2001;50:1126–1133
  32. Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003;46:459–469
  33. Higashiura K, Ura N, Ohata J, et al. Correlations of adiponectin level with insulin resistance and atherosclerosis in Japanese male populations. Clin Endocrinol. 2004;61:753–759
  34. Ryan AS, Berman DM, Nicklas BJ, et al. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care. 2003;26:2383–2388

PII: S0026-0495(05)00362-8

doi: 10.1016/j.metabol.2005.09.005

Metabolism - Clinical and Experimental
Volume 55, Issue 3 , Pages 324-330 , March 2006

Article Tools

* Image Usage & Resolution